MUSTANG BIO, INC. (MBIO) › Operating Cash FlowMUSTANG BIO, INC. (MBIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$4.13M2017: -$12.95M2018: -$19.24M2019: -$33.58M2020: -$37.32M2021: -$53.67M2022: -$65.07M2023: -$49.48M2024: -$11.41M2025: -$5.26M-$5.26M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$5.26M+53.9%2024-$11.41M+76.9%2023-$49.48M+24.0%2022-$65.07M-21.2%2021-$53.67M-43.8%2020-$37.32M-11.1%2019-$33.58M-74.5%2018-$19.24M-48.6%2017-$12.95M-213.6%2016-$4.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share